New potent antibacterial oxazolidinone (MRX-I) with an improved class safety profile. [electronic resource]
Producer: 20140820Description: 4487-97 p. digitalISSN:- 1520-4804
- Acetamides -- adverse effects
- Animals
- Anti-Bacterial Agents -- adverse effects
- Bone Marrow Cells -- cytology
- Clinical Trials, Phase I as Topic
- Drug Design
- Drug Resistance, Bacterial
- Gram-Positive Bacteria -- drug effects
- Gram-Positive Bacterial Infections -- drug therapy
- Humans
- Linezolid
- Monoamine Oxidase Inhibitors -- chemistry
- Oxazolidinones -- adverse effects
- Pyridones -- adverse effects
- Sepsis -- drug therapy
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.